CERo Therapeutics
CERO
trading on NASDAQ
since 2024
$16.80
(Δ 144.61%)
+$9.93 since open
CERo Therapeutics is a biotechnology company focused on developing innovative cancer treatments using gene-editing technologies like CRISPR-Cas9 to create targeted therapies for various cancers, including those involving B-cell malignancies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $10.42 | $26.99 | $10.35 | $164.84K | 57.44M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$1.59 | n/a | +Inf | -Inf% | -Inf% | 0% |